Trademarkia Logo

Canada

C$
Trademark Search in Canada
TERLIVAZ TERLIPRESSIN FOR INJECTION & DESIGN

View On IC.GC.CA

TERLIVAZ TERLIPRESSIN FOR INJECTION & DESIGN
REGISTERED

on 2 Aug 2024

Last Applicant/ Owned by

MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED

College Business & Technology Park, Cruiserath RoadBlanchardstown, Dublin 15, D15 TX2V

IE

Serial Number

2043031 filed on 29th Jul 2020

Registration Number

TMA1247798 registered on 2th Aug 2024

Registration expiry Date

2th Aug 2034

Correspondent Address

MOFFAT & CO.

P.O. Box 2088, Station DOttawa

ONTARIO

CA

K1P5W3

TERLIVAZ TERLIPRESSIN FOR INJECTION & DESIGN

Trademark usage description

pharmaceutical drugs for the treatment of hepatorenal syndrome (hrs)

Vienna Information

26 . 11 . 1

One line or one bandUne ligne ou une bande

26 . 11 . 12

Curved lines or bands (except a 26.11.13)Lignes ou bandes courbes (excepté a 26.11.13)

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 11

Letters underlined, overlined, framed or barred by one or more strokesLettres soulignées, surlignées, encadrées ou barrées d'un ou de plusieurs traits

Classification Information

Class [005]
Pharmaceutical drugs for the treatment of hepatorenal syndrome (HRS)

Classification kind code

11

Mark Details

Serial Number

2043031

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 48
on 16th May 2024		Agent Changed
Submitted for opposition 42
on 15th May 2024		Advertised
Submitted for opposition 26
on 18th Apr 2024		Approved
Submitted for opposition 27
on 18th Apr 2024		Approval Notice Sent
Submitted for opposition 22
on 10th Jan 2024		Search Recorded
Submitted for opposition 20
on 10th Jan 2024		Examiner's First Report
Submitted for opposition 287
on 17th Jun 2022		Pre-Assessment Letter Sent
Submitted for opposition 30
on 29th Jul 2020		Filed
Submitted for opposition 1
on 29th Jul 2020		Created
Submitted for opposition 31
on 29th Jul 2020		Formalized